profit from every NOK 100 of sales.
NOK 0NOK 100
Aker BioMarine
We have no price for Aker BioMarine since 5 October 2026. It may have been taken over, merged or renamed, so the figures below are from then.
NOK 122.00+0.00% today
+42.7% in 1 year
1-year low NOK 80.001-year high NOK 135.40
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Aker BioMarine sold, what it kept, and what it did with the cash.
Sales went from NOK 277 million in 2022 to NOK 218 million in 2025, with -NOK 22.8 million of profit last year.
SalesProfit
Aker BioMarine vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from NOK 100 of sales | Sales growth a year | Price per NOK 1 of profit |
|---|---|---|---|
| Aker BioMarine | No profit yet | ||
 Nestlé | 24.5× · Fair price | ||
 Danone | 23.9× · Fair price | ||
 JBS | 21.3× · Fair price | ||
 Foshan Haitian Flavouring and Food | 29.3× · Fair price |
AI analysis
An AI analyst reads Aker BioMarine's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of NOK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 277 | 196 | 199 | 218 | |
| 115 | 72 | 78 | 98 | |
| 19 | -10 | -5 | 13 | |
| 82 | 40 | 38 | 33 | |
| 10 | -9 | 183 | -23 | |
| 0.11 | -0.10 | 2.09 | -0.26 | |
| 41.4% | 36.9% | 39.4% | 44.8% | |
| 6.9% | -5.3% | -2.7% | 5.9% | |
| 3.6% | -4.6% | 91.8% | -10.5% |
Balance sheet
| In millions of NOK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 822 | 827 | 380 | 389 |
| Cash | 21 | 25 | 14 | 16 |
| Total debt | 381 | 393 | 147 | 182 |
| Total liabilities | 444 | 461 | 214 | 245 |
| 379 | 367 | 167 | 144 | |
| 88 | 88 | 88 | 88 | |
| 3.3% | -1.3% | -2.4% | 2.7% | |
| 2.6% | -2.5% | 109.7% | -15.8% |
Cash flow
| In millions of NOK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 15 | 47 | 12 | 4 | |
| 46 | 49 | 23 | 9 | |
| -31 | -2 | -11 | -5 | |
| Dividends paid | – | – | 373 | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- –
- –
- –
- 58.7×
- 48.1×
- –
- 324.8×
- -0.0%
- -0.2%
- –
Profitability
- 44.8%
- 5.9%
- -10.5%
- –
- 2.7%
- 0.6%
- –
- –
- –
- –
Growth
- −7.7%
- –
- –
- –
- +0.0%
Financial health
- 5.1×
- 1.26
- –
- 0.8×
- 2.57
- –
- –
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 8%of 670
Bottom 28%of 674
Bottom 4%of 673
Bottom 13%of 668
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
15No pass
Benjamin Graham
28No pass
Philip Fisher
31No pass
Peter Lynch
17No pass
Joel Greenblatt
0No pass
Charlie Munger
27No pass
Terry Smith
21No pass
Questions about Aker BioMarine
Is Aker BioMarine a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Aker BioMarine AI analysis
What does Aker BioMarine do?
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. The company operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. It is in Packaged Foods, based in Lysaker, Norway, with 258 employees.
Is Aker BioMarine stock halal?
Yes. Aker BioMarine passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has Aker BioMarine stock done over the past year?
Up 42.7% over the past twelve months, to NOK 122.00. It traded between NOK 80.00 and NOK 135.40 and is 9.9% below its high.
Who are Aker BioMarine's competitors?
The largest listed companies in the same industry are Nestlé, Danone, JBS and Foshan Haitian Flavouring and Food. The peers table on this page compares their profit, growth and price with Aker BioMarine's.
Prices: daily closes to Oct 5, 2026. Fundamentals: company reports via invest-like data.